Embla Medical hf. (OSSFF)

Avangrid Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	873.51	854.89	785.68	718.65	718.67	629.5
Revenue Growth (YoY)	6.57%	8.81%	9.33%	-0.00%	14.16%	-8.27%
Cost of Revenue	325.53	320.19	300.11	278.9	263.28	238.27
Gross Profit	547.98	534.7	485.57	439.75	455.39	391.24
Selling, General & Admin	384.44	380.12	359.97	338.59	328.03	306.95
Research & Development	42.92	40.83	38.14	34.02	31.74	31.02
Operating Expenses	427.36	420.95	398.11	372.61	359.76	337.97
Operating Income	120.62	113.75	87.46	67.14	95.62	53.27
Interest Expense	-21.1	-23.25	-17.96	-11.2	-9.8	-9.61
Interest & Investment Income	1.63	1.97	3.45	0.78	0.17	0.46
Earnings From Equity Investments	6.04	3.34	3.4	0.36	0.4	0.29
Currency Exchange Gain (Loss)	-10.47	-4.44	-0.67	2.61	1.12	-5.88
Other Non Operating Income (Expenses)	0.64	0.19	0.33	-3.51	-0.87	-3.86
EBT Excluding Unusual Items	97.35	91.56	76.01	56.17	86.64	34.66
Merger & Restructuring Charges	-1	-1	-	-	-	-
Impairment of Goodwill	-	-	-	-	-	-5.25
Gain (Loss) on Sale of Assets	-	-	-	-	-	-5.37
Asset Writedown	-	-	-	-	-	-11.33
Pretax Income	96.35	90.56	76.01	56.17	86.64	12.72
Income Tax Expense	22.62	21.6	17.21	12.96	20.98	4.8
Earnings From Continuing Operations	73.73	68.96	58.8	43.21	65.66	7.92
Minority Interest in Earnings	-0.6	-0.68	-0.41	-0.7	-1.66	-1.71
Net Income	73.14	68.28	58.39	42.51	63.99	6.21
Net Income to Common	73.14	68.28	58.39	42.51	63.99	6.21
Net Income Growth	19.71%	16.94%	37.34%	-33.57%	929.84%	-90.59%
Shares Outstanding (Basic)	425	427	420	418	422	422
Shares Outstanding (Diluted)	425	427	420	418	423	423
Shares Change (YoY)	-0.80%	1.51%	0.60%	-1.17%	0.02%	-0.43%
EPS (Basic)	0.17	0.16	0.14	0.10	0.15	0.01
EPS (Diluted)	0.17	0.16	0.14	0.10	0.15	0.01
EPS Growth	20.68%	15.20%	36.53%	-32.78%	929.72%	-90.55%
Free Cash Flow	98.49	89.03	65.09	44.22	83.57	78.47
Free Cash Flow Per Share	0.23	0.21	0.15	0.11	0.20	0.19
Gross Margin	62.73%	62.55%	61.80%	61.19%	63.37%	62.15%
Operating Margin	13.81%	13.31%	11.13%	9.34%	13.31%	8.46%
Profit Margin	8.37%	7.99%	7.43%	5.92%	8.91%	0.99%
Free Cash Flow Margin	11.28%	10.42%	8.29%	6.15%	11.63%	12.47%
EBITDA	141.75	137.92	108.29	89.45	119.86	77.01
EBITDA Margin	16.23%	16.13%	13.78%	12.45%	16.68%	12.23%
D&A For EBITDA	21.13	24.16	20.83	22.31	24.23	23.75
EBIT	120.62	113.75	87.46	67.14	95.62	53.27
EBIT Margin	13.81%	13.31%	11.13%	9.34%	13.31%	8.46%
Effective Tax Rate	23.48%	23.85%	22.64%	23.08%	24.22%	37.73%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.